Pliant Therapeutics, Inc. IPO Research Information

Pliant Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Pliant Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Pliant Therapeutics, Inc.	PLRX - NASDAQ	Last Trade $30.28	$30.00	$0.00	8.33 million	1/25/2023
Underwriter(s): JP Morgan, Piper Sandler, RBC
Co-Manager(s): Cantor, Oppenheimer, HC Wainwright
Industry: Health Care
Filing(s):

Pliant Therapeutics, Inc. Quote & Chart - Click for current quote - PLRX

About Pliant Therapeutics, Inc. (adapted from Pliant Therapeutics, Inc. prospectus):
They are a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PLRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.